Hansa Biopharma AB (HNSA) — Net Asset Momentum
Hansa Biopharma AB (HNSA) recorded a net asset momentum of -251.4% as of December 2024, with net assets of Skr-589.83 Million SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See net assets of Hansa Biopharma AB for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Hansa Biopharma AB Net Asset Momentum (2008–2024)
This chart tracks Hansa Biopharma AB's year-over-year net asset growth across 17 annual reporting periods from 2008 to 2024. The most recent momentum reading is -251.4%, with net assets of Skr-589.83 Million SEK as of December 2024. For live market cap and overall valuation, see Hansa Biopharma AB market cap and net worth.
Annual Net Asset History for Hansa Biopharma AB (2008–2024)
The table below shows the complete annual net asset history for Hansa Biopharma AB from 2008 to 2024, covering 17 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Hansa Biopharma AB (HNSA) tangible net worth to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | Skr-589.83 Million | Skr800.64 Million | Skr1.39 Billion | ▼ -251.4% |
| 2023 | Skr-167.88 Million | Skr1.02 Billion | Skr1.19 Billion | ▼ -127.8% |
| 2022 | Skr602.91 Million | Skr1.69 Billion | Skr1.08 Billion | ▼ -20.4% |
| 2021 | Skr757.57 Million | Skr1.01 Billion | Skr255.24 Million | ▼ -39.0% |
| 2020 | Skr1.24 Billion | Skr1.43 Billion | Skr192.37 Million | ▲ +120.7% |
| 2019 | Skr562.82 Million | Skr664.24 Million | Skr101.42 Million | ▼ -34.5% |
| 2018 | Skr859.88 Million | Skr944.82 Million | Skr84.94 Million | ▲ +36.3% |
| 2017 | Skr630.66 Million | Skr680.41 Million | Skr49.75 Million | ▲ +122.3% |
| 2016 | Skr283.69 Million | Skr310.67 Million | Skr26.98 Million | ▲ +34.1% |
| 2015 | Skr211.53 Million | Skr224.09 Million | Skr12.56 Million | ▲ +324.7% |
| 2014 | Skr49.80 Million | Skr54.31 Million | Skr4.51 Million | ▲ +9.0% |
| 2013 | Skr45.68 Million | Skr50.78 Million | Skr5.10 Million | ▼ -27.8% |
| 2012 | Skr63.24 Million | Skr65.80 Million | Skr2.56 Million | ▲ +82.2% |
| 2011 | Skr34.71 Million | Skr40.90 Million | Skr6.19 Million | ▲ +7.9% |
| 2010 | Skr32.17 Million | Skr37.80 Million | Skr5.64 Million | ▲ +29.1% |
| 2009 | Skr24.92 Million | Skr38.15 Million | Skr13.23 Million | ▼ -38.8% |
| 2008 | Skr40.73 Million | Skr44.87 Million | Skr4.13 Million | — |